Antimutagenicity and Antiproliferative Studies of Lipidic Extracts from White Shrimp (Litopenaeus vannamei)

An organic extract from fresh shrimp (Litopenaeus vannamei) was studied for antimutagenic and antiproliferative properties using Salmonella typhimurium tester strains TA98 and TA100 with metabolic activation (S9) and a cancer cell line (B-cell lymphoma), respectively. Shrimp extract was sequentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson-Sanchez, Griselda, Moreno-Félix, Carolina, Velazquez, Carlos, Plascencia-Jatomea, Maribel, Acosta, Anita, Machi-Lara, Lorena, Aldana-Madrid, María-Lourdes, Ezquerra-Brauer, Josafat-Marina, Robles-Zepeda, Ramón, Burgos-Hernandez, Armando
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996177/
https://www.ncbi.nlm.nih.gov/pubmed/21139845
http://dx.doi.org/10.3390/md8112795
Descripción
Sumario:An organic extract from fresh shrimp (Litopenaeus vannamei) was studied for antimutagenic and antiproliferative properties using Salmonella typhimurium tester strains TA98 and TA100 with metabolic activation (S9) and a cancer cell line (B-cell lymphoma), respectively. Shrimp extract was sequentially fractionated by thin layer chromatography (TLC) and each fraction was tested for antimutagenic and antiproliferative activities. Crude organic extracts obtained from shrimp reduced the number of revertants caused by aflatoxina B(1), showing a dose-response type of relationship. Sequential TLC fractionation of the active extracts produced several antimutagenic and/or antiproliferative fractions. These results suggested that the lipid fraction of the tested species contained compounds with chemoprotective properties that reduce the mutagenicity of AFB(1) and proliferation of a cancer cell line.

Ejemplares similares